Nobori-Biolimus-Eluting Stents versus Resolute Zotarolimus-Eluting Stents in Patients Undergoing Coronary Intervention: A Propensity Score Matching.

CONCLUSION: In this cohort of patients treated with BES or ZES, the rate of MACCEs at 1 year was low and significantly not different between both groups.
PMID: 28120558 [PubMed - in process]

Source: Yonsei Medical Journal - January 27, 2017 Category: Universities & Medical Training Authors: Tantawy A, Ahn CM, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK Tags: Yonsei Med J Source Type: research